Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 59

1.

Glycosylation States of Pre- and Post-synaptic Markers of 5-HT Neurons Differ With Sex and 5-HTTLPR Genotype in Cortical Autopsy Samples.

Nyarko JNK, Quartey MO, Heistad RM, Pennington PR, Poon LJ, Knudsen KJ, Allonby O, El Zawily AM, Freywald A, Rauw G, Baker GB, Mousseau DD.

Front Neurosci. 2018 Aug 10;12:545. doi: 10.3389/fnins.2018.00545. eCollection 2018.

2.

Interactions Among Polymorphisms of Susceptibility Loci for Alzheimer's Disease or Depressive Disorder.

Kitzlerová E, Fišar Z, Lelková P, Jirák R, Zvěřová M, Hroudová J, Manukyan A, Martásek P, Raboch J.

Med Sci Monit. 2018 Apr 28;24:2599-2619. doi: 10.12659/MSM.907202.

3.

Association Study and Meta-Analysis of Polymorphisms, Methylation Profiles, and Peripheral mRNA Expression of the Serotonin Transporter Gene in Patients with Alzheimer's Disease.

Yamazaki K, Yoshino Y, Mori T, Okita M, Yoshida T, Mori Y, Ozaki Y, Sao T, Iga J, Ueno S.

Dement Geriatr Cogn Disord. 2016;41(5-6):334-47. doi: 10.1159/000447324. Epub 2016 Jul 15.

PMID:
27414430
4.

Pharmacological Modulations of the Serotonergic System in a Cell-Model of Familial Alzheimer's Disease.

Tajeddinn W, Persson T, Calvo-Garrido J, Seed Ahmed M, Maioli S, Vijayaraghavan S, Kazokoglu MS, Parrado-Fernández C, Yoshitake T, Kehr J, Francis P, Winblad B, Höglund K, Cedazo-Minguez A, Aarsland D.

J Alzheimers Dis. 2016 May 7;53(1):349-61. doi: 10.3233/JAD-160046.

PMID:
27163814
5.

Depression as a risk factor for Alzheimer's disease: Genes, steroids, cytokines and neurogenesis - What do we need to know?

Herbert J, Lucassen PJ.

Front Neuroendocrinol. 2016 Apr;41:153-71. doi: 10.1016/j.yfrne.2015.12.001. Epub 2015 Dec 30. Review.

PMID:
26746105
6.

5-HT1B and other related serotonergic proteins are altered in APPswe mutation.

Tajeddinn W, Persson T, Maioli S, Calvo-Garrido J, Parrado-Fernandez C, Yoshitake T, Kehr J, Francis P, Winblad B, Höglund K, Cedazo-Minguez A, Aarsland D.

Neurosci Lett. 2015 May 6;594:137-43. doi: 10.1016/j.neulet.2015.03.064. Epub 2015 Apr 1.

PMID:
25841787
7.

The JAK/STAT3 pathway is a common inducer of astrocyte reactivity in Alzheimer's and Huntington's diseases.

Ben Haim L, Ceyzériat K, Carrillo-de Sauvage MA, Aubry F, Auregan G, Guillermier M, Ruiz M, Petit F, Houitte D, Faivre E, Vandesquille M, Aron-Badin R, Dhenain M, Déglon N, Hantraye P, Brouillet E, Bonvento G, Escartin C.

J Neurosci. 2015 Feb 11;35(6):2817-29. doi: 10.1523/JNEUROSCI.3516-14.2015.

8.

Targeting ATM ameliorates mutant Huntingtin toxicity in cell and animal models of Huntington's disease.

Lu XH, Mattis VB, Wang N, Al-Ramahi I, van den Berg N, Fratantoni SA, Waldvogel H, Greiner E, Osmand A, Elzein K, Xiao J, Dijkstra S, de Pril R, Vinters HV, Faull R, Signer E, Kwak S, Marugan JJ, Botas J, Fischer DF, Svendsen CN, Munoz-Sanjuan I, Yang XW.

Sci Transl Med. 2014 Dec 24;6(268):268ra178. doi: 10.1126/scitranslmed.3010523.

PMID:
25540325
9.

No association of SLC6A3 and SLC6A4 gene polymorphisms with schizophrenia in the Han Chinese population.

Yang B, Huang X, Ruan L, Yu T, Li X, Jesse FF, Cao Y, Li X, Liu B, Yang F, Lee YS, He L, Li W, He G.

Neurosci Lett. 2014 Sep 5;579:114-8. doi: 10.1016/j.neulet.2014.07.004. Epub 2014 Jul 11.

PMID:
25019689
10.

Investigation of association of serotonin transporter and monoamine oxidase-A genes with Alzheimer's disease and depression in the VITA study cohort: a 90-month longitudinal study.

Scholz CJ, Jungwirth S, Danielczyk W, Weber H, Wichart I, Tragl KH, Fischer P, Riederer P, Deckert J, Grünblatt E.

Am J Med Genet B Neuropsychiatr Genet. 2014 Mar;165B(2):184-91. doi: 10.1002/ajmg.b.32220. Epub 2014 Jan 17.

PMID:
24443391
11.

Behavioral therapy reverses circadian deficits in a transgenic mouse model of Huntington's disease.

Cuesta M, Aungier J, Morton AJ.

Neurobiol Dis. 2014 Mar;63:85-91. doi: 10.1016/j.nbd.2013.11.008. Epub 2013 Nov 20.

PMID:
24269914
12.

Determining the association of the 5HTTLPR polymorphism with delusions and hallucinations in Lewy body dementias.

Creese B, Ballard C, Aarsland D, Londos E, Sharp S, Jones E.

Am J Geriatr Psychiatry. 2014 Jun;22(6):580-6. doi: 10.1016/j.jagp.2012.11.001. Epub 2013 Apr 9.

PMID:
23582751
13.

Brain-specific tryptophan hydroxylase, TPH2, and 5-HTTLPR are associated with frontal lobe symptoms in Alzheimer's disease.

Engelborghs S, Sleegers K, Van der Mussele S, Le Bastard N, Brouwers N, Van Broeckhoven C, De Deyn PP.

J Alzheimers Dis. 2013;35(1):67-73. doi: 10.3233/JAD-101305.

PMID:
23334703
14.

The serotonin transporter gene locus in late-life major depressive disorder.

Seripa D, Panza F, D'Onofrio G, Paroni G, Bizzarro A, Fontana A, Paris F, Cascavilla L, Copetti M, Masullo C, Pilotto A.

Am J Geriatr Psychiatry. 2013 Jan;21(1):67-77. doi: 10.1016/j.jagp.2012.10.012. Epub 2013 Jan 2.

PMID:
23290204
15.

Serotonin transporter and serotonin receptor 2A gene polymorphisms in Alzheimer's disease.

Fehér A, Juhász A, László A, Pákáski M, Kálmán J, Janka Z.

Neurosci Lett. 2013 Feb 8;534:233-6. doi: 10.1016/j.neulet.2012.12.020. Epub 2012 Dec 27.

PMID:
23274704
16.

Connectomic intermediate phenotypes for psychiatric disorders.

Fornito A, Bullmore ET.

Front Psychiatry. 2012 Apr 19;3:32. doi: 10.3389/fpsyt.2012.00032. eCollection 2012.

17.

A novel study and meta-analysis of the genetic variation of the serotonin transporter promoter in the italian population do not support a large effect on Alzheimer's disease risk.

Polito L, Prato F, Rodilossi S, Ateri E, Galimberti D, Scarpini E, Clerici F, Mariani C, Forloni G, Albani D.

Int J Alzheimers Dis. 2011;2011:312341. doi: 10.4061/2011/312341. Epub 2011 Jun 2.

18.

Serotonin transporter and saitohin genes in risk of Alzheimer's disease and frontotemporal lobar dementia: preliminary findings.

Lorenzi C, Marcone A, Pirovano A, Marino E, Cordici F, Cerami C, Delmonte D, Cappa SF, Bramanti P, Smeraldi E.

Neurol Sci. 2010 Dec;31(6):741-9. doi: 10.1007/s10072-010-0400-8. Epub 2010 Sep 18.

PMID:
20852909
19.

Serotonergic system genes in psychosis of Alzheimer dementia: meta-analysis.

Ramanathan S, Glatt SJ.

Am J Geriatr Psychiatry. 2009 Oct;17(10):839-46. doi: 10.1097/JGP.0b013e3181ab8c3f.

PMID:
19910872
20.

The serotonin transporter promoter polymorphic region is not a risk factor for Alzheimer's disease related behavioral disturbances.

Albani D, Prato F, Tettamanti M, Lovati C, Galimberti D, Restelli I, Mariani C, Quadri PL, Scarpini E, Lucca U, Forloni G.

J Alzheimers Dis. 2009;18(1):125-30. doi: 10.3233/JAD-2009-1129.

PMID:
19625753

Supplemental Content

Loading ...
Support Center